Tonix Pharmaceuticals has filed a registration statement to sell up to $500 million in securities. The company’s lead drug candidate is for the management of fibromyalgia pain.
Tonix Pharmaceuticals has filed a registration statement to sell up to $500 million in securities. The company’s lead drug candidate is for the management of fibromyalgia pain.
Copyright © Louis Velazquez. All Rights Reserved.